Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

[E-health education in undergraduate medical schools in Sweden].

Hoffmann F, Nordgren H.

Lakartidningen. 2019 May 7;116. pii: FMA4. Swedish.

2.

Vårdpersonal bör vara öppna för att dra nytta av e-hälsa.

Hoffmann M, Lövström R, Nordgren H.

Lakartidningen. 2018 Feb 26;115. pii: E3CF. Swedish. No abstract available.

3.

Questionnaire survey of detrimental fur animal epidemic necrotic pyoderma in Finland.

Nordgren H, Vapalahti K, Vapalahti O, Sukura A, Virtala AM.

Acta Vet Scand. 2017 Aug 3;59(1):54. doi: 10.1186/s13028-017-0322-z.

4.

Experimental Infection of Mink Enforces the Role of Arcanobacterium phocae as Causative Agent of Fur Animal Epidemic Necrotic Pyoderma (FENP).

Nordgren H, Aaltonen K, Raunio-Saarnisto M, Sukura A, Vapalahti O, Sironen T.

PLoS One. 2016 Dec 14;11(12):e0168129. doi: 10.1371/journal.pone.0168129. eCollection 2016.

5.

Characterization of a new epidemic necrotic pyoderma in fur animals and its association with Arcanobacterium phocae infection.

Nordgren H, Aaltonen K, Sironen T, Kinnunen PM, Kivistö I, Raunio-Saarnisto M, Moisander-Jylhä AM, Korpela J, Kokkonen UM, Hetzel U, Sukura A, Vapalahti O.

PLoS One. 2014 Oct 10;9(10):e110210. doi: 10.1371/journal.pone.0110210. eCollection 2014.

6.

Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma - pathological development and restitution.

Hallén K, Sangfelt P, Nilsson T, Nordgren H, Wanders A, Molin D.

Acta Oncol. 2014 Sep;53(9):1271-5. doi: 10.3109/0284186X.2014.897001. Epub 2014 Apr 3. No abstract available.

PMID:
24697745
7.

EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.

Wei Q, Shui Y, Zheng S, Wester K, Nordgren H, Nygren P, Glimelius B, Carlsson J.

Oncol Rep. 2011 Jan;25(1):3-11.

PMID:
21109951
8.

The physician at a distance: the use of videoconferencing in the treatment of patients with hypertension.

Nilsson M, Rasmark U, Nordgren H, Hallberg P, Skönevik J, Westman G, Rolandsson O.

J Telemed Telecare. 2009;15(8):397-403. doi: 10.1258/jtt.2009.090509.

PMID:
19948706
9.

Cervical metastasis from Spitz nevus of the buccal mucosa.

Zätterström U, Thor A, Nordgren H.

Melanoma Res. 2008 Feb;18(1):36-9. doi: 10.1097/CMR.0b013e3282f356e4.

PMID:
18227706
10.

EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.

Wei Q, Sheng L, Shui Y, Hu Q, Nordgren H, Carlsson J.

Ann Surg Oncol. 2008 Apr;15(4):1193-201. doi: 10.1245/s10434-007-9771-3. Epub 2008 Jan 3.

PMID:
18172732
11.

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D, Marth C, Mueller-Holzner E, Corcoran M, Dagnell M, Nejad SZ, Nayer BN, Zali MR, Hansson J, Egyhazi S, Petersson F, Sangfelt P, Nordgren H, Grander D, Reed SI, Widschwendter M, Sangfelt O, Spruck C.

Cancer Res. 2007 Oct 1;67(19):9006-12. Erratum in: Cancer Res. 2008 Feb 15;68(4):1245. Dofou, Dimitra [corrected to Dafou, Dimitra].

12.

EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases.

Wei Q, Chen L, Sheng L, Nordgren H, Wester K, Carlsson J.

Int J Oncol. 2007 Sep;31(3):493-9.

PMID:
17671674
13.

Search for DNA of exogenous mouse mammary tumor virus-related virus in human breast cancer samples.

Bindra A, Muradrasoli S, Kisekka R, Nordgren H, Wärnberg F, Blomberg J.

J Gen Virol. 2007 Jun;88(Pt 6):1806-9.

PMID:
17485542
14.

A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer.

Villman K, Ohd JF, Lidbrink E, Malmberg L, Lindh B, Blomqvist C, Nordgren H, Bergh J, Bergström D, Ahlgren J.

Eur J Cancer. 2007 May;43(7):1153-60. Epub 2007 Mar 29.

PMID:
17398088
15.

Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome.

Bergqvist J, Ohd JF, Smeds J, Klaar S, Isola J, Nordgren H, Elmberger GP, Hellborg H, Bjohle J, Borg AL, Skoog L, Bergh J.

Ann Oncol. 2007 May;18(5):845-50. Epub 2007 Mar 9.

16.

[177Lu]pertuzumab: experimental therapy of HER-2-expressing xenografts.

Persson M, Gedda L, Lundqvist H, Tolmachev V, Nordgren H, Malmström PU, Carlsson J.

Cancer Res. 2007 Jan 1;67(1):326-31.

17.

Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial.

Ringberg A, Nordgren H, Thorstensson S, Idvall I, Garmo H, Granstrand B, Arnesson LG, Sandelin K, Wallgren A, Anderson H, Emdin S, Holmberg L.

Eur J Cancer. 2007 Jan;43(2):291-8. Epub 2006 Nov 21.

PMID:
17118648
18.

Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, Wong JE, Liu ET, Bergh J, Kuznetsov VA, Miller LD.

Cancer Res. 2006 Nov 1;66(21):10292-301.

19.

Determination of lamotrigine and its metabolites in human plasma by liquid chromatography-mass spectrometry.

Beck O, Ohman I, Nordgren HK.

Ther Drug Monit. 2006 Oct;28(5):603-7.

PMID:
17038873
20.

SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening.

Emdin SO, Granstrand B, Ringberg A, Sandelin K, Arnesson LG, Nordgren H, Anderson H, Garmo H, Holmberg L, Wallgren A; Swedish Breast Cancer Group.

Acta Oncol. 2006;45(5):536-43.

PMID:
16864166
21.

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.

Hall P, Ploner A, Bjöhle J, Huang F, Lin CY, Liu ET, Miller LD, Nordgren H, Pawitan Y, Shaw P, Skoog L, Smeds J, Wedrén S, Ohd J, Bergh J.

BMC Med. 2006 Jun 30;4:16.

22.

Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen.

Bergqvist J, Elmberger G, Ohd J, Linderholm B, Bjohle J, Hellborg H, Nordgren H, Borg AL, Skoog L, Bergh J.

Eur J Cancer. 2006 May;42(8):1104-12. Epub 2006 Apr 5.

PMID:
16603346
23.

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M.

J Natl Cancer Inst. 2006 Feb 15;98(4):262-72.

PMID:
16478745
24.

25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.

Segersten U, Holm PK, Björklund P, Hessman O, Nordgren H, Binderup L, Akerström G, Hellman P, Westin G.

Breast Cancer Res. 2005;7(6):R980-6. Epub 2005 Oct 6.

25.

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, Liu ET, Miller L, Nordgren H, Ploner A, Sandelin K, Shaw PM, Smeds J, Skoog L, Wedrén S, Bergh J.

Breast Cancer Res. 2005;7(6):R953-64. Epub 2005 Oct 3.

26.

Application of direct urine LC-MS-MS analysis for screening of novel substances in drug abusers.

Nordgren HK, Holmgren P, Liljeberg P, Eriksson N, Beck O.

J Anal Toxicol. 2005 May-Jun;29(4):234-9.

PMID:
15975252
27.
28.

Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue.

Ekberg T, Nestor M, Engström M, Nordgren H, Wester K, Carlsson J, Anniko M.

Int J Oncol. 2005 May;26(5):1177-85.

PMID:
15809707
29.

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review.

Carlsson J, Nordgren H, Sjöström J, Wester K, Villman K, Bengtsson NO, Ostenstad B, Lundqvist H, Blomqvist C.

Br J Cancer. 2004 Jun 14;90(12):2344-8. Review.

30.

HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer.

Brattström D, Wester K, Bergqvist M, Hesselius P, Malmström PU, Nordgren H, Wagenius G, Brodin O.

Acta Oncol. 2004;43(1):80-6.

PMID:
15068324
31.

Oral cancer after using Swedish snus (smokeless tobacco) for 70 years - a case report.

Zatterstrom UK, Svensson M, Sand L, Nordgren H, Hirsch JM.

Oral Dis. 2004 Jan;10(1):50-3.

PMID:
14996295
32.

Multicomponent screening for drugs of abuse: direct analysis of urine by LC-MS-MS.

Nordgren HK, Beck O.

Ther Drug Monit. 2004 Feb;26(1):90-7.

PMID:
14749556
33.

Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.

Lindahl T, Landberg G, Ahlgren J, Nordgren H, Norberg T, Klaar S, Holmberg L, Bergh J.

Carcinogenesis. 2004 Mar;25(3):375-80. Epub 2003 Nov 21.

PMID:
14633656
34.

Risk factors for local recurrence after breast-conserving surgery.

Fredriksson I, Liljegren G, Palm-Sjövall M, Arnesson LG, Emdin SO, Fornander T, Lindgren A, Nordgren H, Idvall I, Holmqvist M, Holmberg L, Frisell J.

Br J Surg. 2003 Sep;90(9):1093-102.

PMID:
12945077
35.

Direct screening of urine for MDMA and MDA by liquid chromatography-tandem mass spectrometry.

Nordgren HK, Beck O.

J Anal Toxicol. 2003 Jan-Feb;27(1):15-9.

PMID:
12587677
36.

[Cross-disciplinary use of medical records is good for cooperation within health care].

Wedén M, Nordgren H.

Lakartidningen. 2003 Jan 9;100(1-2):64-5. Swedish. No abstract available.

PMID:
12572140
37.

Ductal carcinoma in situ of the breast: a new phenotype classification system and its relation to prognosis.

Wärnberg F, Casalini P, Nordgren H, Bergkvist L, Holmberg L, Ménard S.

Breast Cancer Res Treat. 2002 Jun;73(3):215-21.

PMID:
12160327
39.

Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort.

Norberg T, Klaar S, Kärf G, Nordgren H, Holmberg L, Bergh J.

Cancer Res. 2001 Nov 15;61(22):8317-21.

40.

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.

Wärnberg F, Nordgren H, Bergkvist L, Holmberg L.

Br J Cancer. 2001 Sep 14;85(6):869-74.

41.

Local breast cancer recurrence caused by mammographically guided punctures.

Thurfjell MG, Jansson T, Nordgren H, Bergh J, Lindgren A, Thurfjell E.

Acta Radiol. 2000 Sep;41(5):435-40.

PMID:
11016762
42.

Human milk fat globule antigen 1 (HMFG1) expression in prostatic carcinoma and immunotargeting with a radiolabelled monoclonal anti-HMFG1 antibody.

Ljung G, Lennernäs B, Nordgren H, Holmberg A, Westlin JE, Nilsson S, Edgren M.

Anticancer Res. 2000 Jul-Aug;20(4):2321-4.

PMID:
10953291
43.

E4, a new monoclonal antibody identifying a human prostatic cell surface antigen

Nilsson S, Essand M, Logdahl P, Larson A, Nordgren H, Juhlin C.

Cancer Biother Radiopharm. 1997 Dec;12(6):395-403.

PMID:
10851493
44.

Ectopic pancreas of the ampulla of Vater.

Hammarström LE, Nordgren H.

Endoscopy. 1999 Nov;31(9):S67. No abstract available.

PMID:
10604636
45.

10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial.

Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabár L, Nordgren H, Adami HO.

J Clin Oncol. 1999 Aug;17(8):2326-33.

PMID:
10561294
46.
47.

A comparative study of apoptosis and necrosis in HepG2 cells: oxidant-induced caspase inactivation leads to necrosis.

Samali A, Nordgren H, Zhivotovsky B, Peterson E, Orrenius S.

Biochem Biophys Res Commun. 1999 Feb 5;255(1):6-11.

PMID:
10082646
48.

Value of sextant biopsies in the assessment of local cure following external beam radiotherapy of prostatic adenocarcinoma.

Almroth A, Ljung G, Eklund T, Nordgren H, Kalafatidis D, Ringqvist I, Nilsson S.

Scand J Urol Nephrol. 1998 Apr;32(2):111-5.

PMID:
9606782
49.

Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy.

Liljegren G, Lindgren A, Bergh J, Nordgren H, Tabár L, Holmberg L.

Ann Oncol. 1997 Mar;8(3):235-41.

50.

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.

Sjögren S, Inganäs M, Norberg T, Lindgren A, Nordgren H, Holmberg L, Bergh J.

J Natl Cancer Inst. 1996 Feb 21;88(3-4):173-82.

PMID:
8632491

Supplemental Content

Loading ...
Support Center